Market Position USD is a global leader in rapid point-of-care testing with a broad catalog including drug and alcohol screens, infectious disease, and women’s health, presenting opportunities to cross-sell complementary tests and expand into adjacent healthcare facilities and clinics.

SMB Focus With 11-50 employees and revenue in the low single-digit millions, USD targets small to mid-sized healthcare providers and facilities, suggesting sales motions tailored to centralized purchasing, bundled offerings, and scalable testing solutions.

Growth Potential The company’s position alongside large laboratory networks implies potential partnerships or reseller agreements to extend reach within established buyer communities and integrated care models.

Tech Stack Current web and analytics technologies indicate opportunities to modernize online product catalogs and enhance digital procurement experiences, potentially reducing sales cycle time and improving lead capture.

Competitive Landscape Operating in a market with large players and labs, USD can capitalize on rapid point-of-care advantages, emphasizing speed, accessibility, and on-site testing capabilities to compete for hospital-affiliate and employer-based screening programs.